These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6706245)

  • 1. Androgenic action of progestins and possible synandrogenic properties of antiandrogens used in oral contraceptives.
    Spona J
    Gynecol Obstet Invest; 1984; 17(2):66-72. PubMed ID: 6706245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
    Kloosterboer HJ; Vonk-Noordegraaf CA; Turpijn EW
    Contraception; 1988 Sep; 38(3):325-32. PubMed ID: 3139361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
    Louw-du Toit R; Perkins MS; Hapgood JP; Africander D
    Biochem Biophys Res Commun; 2017 Sep; 491(1):140-146. PubMed ID: 28711501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestational and androgenic receptor binding affinities and in vivo activities of norgestimate and other progestins.
    Phillips A; Demarest K; Hahn DW; Wong F; McGuire JL
    Contraception; 1990 Apr; 41(4):399-410. PubMed ID: 2335104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestins can mimic, inhibit and potentiate the actions of androgens.
    Bardin CW; Brown T; Isomaa VV; Jänne OA
    Pharmacol Ther; 1983; 23(3):443-59. PubMed ID: 6371845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contraceptive progestins. Various 11-substituents combined with four 17-substituents: 17alpha-ethynyl, five- and six-membered spiromethylene ethers or six-membered spiromethylene lactones.
    Schoonen WG; Deckers G; de Gooijer ME; de Ries R; Mathijssen-Mommers G; Hamersma H; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):109-23. PubMed ID: 11086230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
    Fuhrmann U; Slater EP; Fritzemeier KH
    Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nestorone: a progestin with a unique pharmacological profile.
    Kumar N; Koide SS; Tsong Y; Sundaram K
    Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of a contraceptive progestogen ORG 2969 and its metabolites to receptor proteins and human sex hormone binding globulin.
    Bergink EW; Hamburger AD; de Jager E; van der Vies J
    J Steroid Biochem; 1981 Feb; 14(2):175-83. PubMed ID: 6451769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
    Juchem M; Pollow K
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2171-83. PubMed ID: 2175153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex hormone receptor binding, progestin selectivity, and the new oral contraceptives.
    Collins DC
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1508-13. PubMed ID: 8178899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors regulating the androgenic action of progestins in mouse kidney.
    Bullock LP; Bardin CW
    Adv Exp Med Biol; 1979; 117():281-95. PubMed ID: 474282
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of progestins on submaxillary gland epidermal growth factor: demonstration of androgenic, synandrogenic and antiandrogenic actions.
    Bullock LP; Barthe PL; Mowszowicz I; Orth DN; Bardin CW
    Endocrinology; 1975 Jul; 97(1):189-95. PubMed ID: 1140168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo metabolism and binding of 6 alpha-methylprogesterone; a progestin with anti-androgenic and synandrogenic activities.
    Brown TR; Bullock LP; Bardin CW
    Adv Exp Med Biol; 1979; 117():269-80. PubMed ID: 474281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate.
    Botella J; Paris J; Lahlou B
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):544-50. PubMed ID: 3630545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Side effects of third generation progestagens].
    Sitruk-ware R
    Contracept Fertil Sex (Paris); 1993 Apr; 21(4):295-300. PubMed ID: 12318229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgenic, synandrogenic, and antiandrogenic actions of progestins.
    Bullock LP; Bardin CW
    Ann N Y Acad Sci; 1977 Mar; 286():321-30. PubMed ID: 281183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin.
    Saartok T; Dahlberg E; Gustafsson JA
    Endocrinology; 1984 Jun; 114(6):2100-6. PubMed ID: 6539197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of progestagens to receptor proteins in MCF-7 cells.
    Bergink EW; van Meel F; Turpijn EW; van der Vies J
    J Steroid Biochem; 1983 Nov; 19(5):1563-70. PubMed ID: 6645495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.